AACR 2017: one presentation and two highly-cited publications

Date Posted: 
2017-04-03

Research excellence at the Vancouver Prostate Centre was demonstrated at the American Association for Cancer Research (AACR) annual meeting, April 1 - 5, 2017.

Dr. Alastair Davies & Dr. Amina Zoubeidi present their work in the Tumor Stem Cell Biology session (April 4, 2017), in a talk titled "EZH2 reprogramming confers intrinsic stem cell properties and developmental plasticity driving neuroendocrine prostate cancer".

Groundbreaking publications led by Dr. Chi and Dr. Gleave were recognized in "The Best of the AACR Journals,” which is a collection of the most-cited articles published in 2015 across the AACR journal portfolio based on the total number of citations from date of publication through January 2017.

The publications are:

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer” Azad et. al., Clinical Cancer Research, 2015 May 15;21(10):2315-24.

Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer" Toren et. al., Molecular Cancer Therapeutics, 2015 Jan;14(1):59-69.
 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Movember Foundation 2018

Movember 2018

The Movember Foundation's fundraiser runs from November 1 to 30.  Click here to donate to The Vancouver Prostate Centre team as we join teams across Canada to raise funds for men's health research in the areas of prostate cancer, testicular cancer, mental health and suicide prevention.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development